S.Korea grants conditional approval for Celltrion’s COVID-19 antibody treatment

South Korea on Friday granted conditional approval to Celltrion Inc's COVID-19 antibody treatment, drug safety minister Kim Gang-lip told a news conference.

The ministry has decided to authorize the drug under the condition of submission of the third clinical trial results, Kim said. The antibody drug is the first locally made coronavirus treatment in the country to win such approval.

Also Read: Entertainment News Roundup: Gary Oldman on 'Mank', streaming and resisting Smiley; South Korean AI technology brings back folk singer's voice and more